IDEXX LABORATORIES INC /DE Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
IDEXX LABORATORIES INC /DE (IDXX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -0.10%, a 111.11% decline from fiscal 2024.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.90%, a 28.57% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.70%, a 50.00% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 1.40%, a 100.00% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.10% 10-K · filed 2026-02-20 | |
| 2024-12-31 | 0.90% 10-K · filed 2026-02-20 | |
| 2023-12-31 | 0.70% 10-K · filed 2026-02-20 | |
| 2022-12-31 | 1.40% 10-K · filed 2025-02-21 | |
| 2021-12-31 | 0.70% 10-K · filed 2024-02-22 | |
| 2020-12-31 | 0.80% 10-K · filed 2023-02-16 | |
| 2019-12-31 | 1.40% 10-K · filed 2022-02-16 | |
| 2018-12-31 | 1.90% 10-K · filed 2021-02-12 | 1.40% 10-K · filed 2019-02-15 |
| 2017-12-31 | 0.80% 10-K · filed 2020-02-14 | 0.20% 10-K · filed 2018-02-16 |
| 2016-12-31 | 0.80% 10-K · filed 2019-02-15 | |
| 2015-12-31 | 1.10% 10-K · filed 2018-02-16 | |
| 2014-12-31 | -0.80% 10-K · filed 2017-02-17 | |
| 2013-12-31 | 0.50% 10-K · filed 2016-02-17 | |
| 2012-12-31 | 0.40% 10-K · filed 2015-02-17 | |
| 2011-12-31 | 0.20% 10-K · filed 2014-02-18 | |
| 2010-12-31 | 0.10% 10-K · filed 2013-02-19 | |
| 2009-12-31 | 0.10% 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |